Atrial Fibrillation Trial, Recruiting (NCT07521800)

Atrial Fibrillation Trial, Recruiting NCT07521800 Sponsor: Medical University of Silesia Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT07521800 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with severe narrowing of the aortic heart valve (severe aortic stenosis)
A medical team has assessed you as being at moderate or high risk from heart-related complications, and has recommended you for a procedure called TAVI (a minimally invasive heart valve replacement)
You are willing and able to give written consent to take part in the study

Who may not be able to join:

You have a history of an irregular heart rhythm called atrial fibrillation or atrial flutter
You have previously known problems with the electrical signalling system of your heart (confirm with trial site)
You have a pacemaker or any implanted heart device, either before or after the TAVI procedure
You have had a stroke, a mini-stroke (TIA), a heart attack, or heart surgery within the last month before being assessed for TAVI
You have had a bleeding stroke within the last year before being assessed for TAVI
You are currently taking long-term medication that suppresses your immune system
You have other health or personal circumstances, such as substance dependency, alcohol misuse, or significant emotional or mental health difficulties, that could make it unsafe for you to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 504827636

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07521800

Sponsor: Medical University of Silesia

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 504827636

More information: https://clinicaltrials.gov/study/NCT07521800

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with severe narrowing of the aortic heart valve (severe aortic stenosis)
A medical team has assessed you as being at moderate or high risk from heart-related complications, and has recommended you for a procedure called TAVI (a minimally invasive heart valve replacement)
You are willing and able to give written consent to take part in the study

Who may not be able to join:

You have a history of an irregular heart rhythm called atrial fibrillation or atrial flutter
You have previously known problems with the electrical signalling system of your heart (confirm with trial site)
You have a pacemaker or any implanted heart device, either before or after the TAVI procedure
You have had a stroke, a mini-stroke (TIA), a heart attack, or heart surgery within the last month before being assessed for TAVI
You have had a bleeding stroke within the last year before being assessed for TAVI
You are currently taking long-term medication that suppresses your immune system
You have other health or personal circumstances, such as substance dependency, alcohol misuse, or significant emotional or mental health difficulties, that could make it unsafe for you to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Silesia

Registry

ClinicalTrials.gov

Start date

1 December 2023

Est. completion

1 February 2027

Where this trial is recruiting

🇮🇹 Italy 🇵🇱 Poland

Primary endpoints

The first primary endpoint will be the assessment of the total incidence of clinically significant atrio-ventricular block.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov